KB001-A / Humanigen  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
KB001-A / Humanigen
KB001-A, NCT01695343: Study to Evaluate the Effect of on Time-to-Need for Antibiotic Treatment

Completed
2
182
US, RoW
KB001-A, Placebo Comparator
Humanigen, Inc.
Cystic Fibrosis
11/14
12/14
NCT00638365: Dose Escalation Study of KB001 in Cystic Fibrosis Patients Infected With Pseudomonas Aeruginosa

Completed
1/2
27
US
KB001, KB001-recombinant human anti-Pa PcrV Fab antibody, Placebo
Humanigen, Inc.
Cystic Fibrosis
03/09
04/09
NCT00691587 / 2007-006764-29: Pilot Trial of KB001 in Mechanically-Ventilated Patients Colonized With Pseudomonas Aeruginosa

Completed
1/2
36
Europe
KB001, Placebo
Humanigen, Inc.
Pseudomonas Aeruginosa, Ventilator Associated Pneumonia
03/09
04/09

Download Options